Enzo Biochem Stock Alpha and Beta Analysis

ENZ Stock  USD 0.98  0.01  1.03%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Enzo Biochem. It also helps investors analyze the systematic and unsystematic risks associated with investing in Enzo Biochem over a specified time horizon. Remember, high Enzo Biochem's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Enzo Biochem's market risk premium analysis include:
Beta
0.28
Alpha
(0.12)
Risk
1.56
Sharpe Ratio
(0.07)
Expected Return
(0.11)
Please note that although Enzo Biochem alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Enzo Biochem did 0.12  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Enzo Biochem stock's relative risk over its benchmark. Enzo Biochem has a beta of 0.28  . As returns on the market increase, Enzo Biochem's returns are expected to increase less than the market. However, during the bear market, the loss of holding Enzo Biochem is expected to be smaller as well. At this time, Enzo Biochem's Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 1.26 in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (1.04).

Enzo Biochem Quarterly Cash And Equivalents

82.37 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Enzo Biochem Backtesting, Enzo Biochem Valuation, Enzo Biochem Correlation, Enzo Biochem Hype Analysis, Enzo Biochem Volatility, Enzo Biochem History and analyze Enzo Biochem Performance.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Enzo Biochem Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Enzo Biochem market risk premium is the additional return an investor will receive from holding Enzo Biochem long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Enzo Biochem. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Enzo Biochem's performance over market.
α-0.12   β0.28

Enzo Biochem expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Enzo Biochem's Buy-and-hold return. Our buy-and-hold chart shows how Enzo Biochem performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Enzo Biochem Market Price Analysis

Market price analysis indicators help investors to evaluate how Enzo Biochem stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enzo Biochem shares will generate the highest return on investment. By understating and applying Enzo Biochem stock market price indicators, traders can identify Enzo Biochem position entry and exit signals to maximize returns.

Enzo Biochem Return and Market Media

The median price of Enzo Biochem for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 1.03 with a coefficient of variation of 1.93. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 1.03, and mean deviation of 0.01. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Cardiac Marker Testing Devices Market Forecast 2024-2031 Growth and Size Projections Explained Enzo Biochem Inc
09/11/2024
2
Enzo Biochem Research Coverage Started at StockNews.com - MarketBeat
09/27/2024
3
Stonegate Initiates Coverage on Sirona Biochem Corp
10/17/2024
4
Update Stonegate Initiates Coverage on Sirona Biochem Corp
10/21/2024
5
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands
10/30/2024

About Enzo Biochem Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Enzo or other stocks. Alpha measures the amount that position in Enzo Biochem has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield2.31E-42.06E-4
Price To Sales Ratio1.821.73

Enzo Biochem Upcoming Company Events

As portrayed in its financial statements, the presentation of Enzo Biochem's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Enzo Biochem's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Enzo Biochem's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Enzo Biochem. Please utilize our Beneish M Score to check the likelihood of Enzo Biochem's management manipulating its earnings.
18th of March 2024
Upcoming Quarterly Report
View
31st of January 2024
Next Fiscal Quarter End
View

Build Portfolio with Enzo Biochem

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.